| Name | Title | Contact Details |
|---|
Amwell (previously known as American Well) is a leading telehealth platform in the United States and globally, connecting and enabling providers, insurers, patients, and innovators to deliver greater access to more affordable, higher quality care. Amwell believes that digital care delivery will transform healthcare. The Company offers a single, comprehensive platform to support all telehealth needs from urgent to acute and post-acute care, behavioral health, as well as chronic care management and healthy living. With over a decade of experience, Amwell powers telehealth solutions for over 240 health systems comprised of 2,000 hospitals and 55 health plan partners with over 36,000 employers, reaching over 150 million lives.
Acucela is a clinical-stage biotechnology company that specializes in discovering and developing novel therapeutics to treat and slow the progression of sight-threatening ophthalmic diseases impacting millions of individuals worldwide. Acucela currently has the following candidates in development with Otsuka Pharmaceutical: emixustat hydrochloride for GA associated with dry AMD based on Acucela’s proprietary visual cycle modulation; and OPA-6566 for ocular hypertension and glaucoma.
Access Therapies is a Indianapolis, IN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Colonial Senior Service is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Hamilton, OH. To find more information about Colonial Senior Service, please visit www.colonialseniors.org
Franklin Group Inc is a Somerville, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.